ConductScience.org, home

Paper3583643

Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs.

Hill BT and 1 other. Invest New Drugs, 1986. Cited by 5 papers, by iCite.

Cite this record

ConductScience Library. Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs. Papers, record 3583643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3583643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Spirogermanium--a novel antitumour agent expressing a lack of cross-resistance in vitro with a range of 'standard' antitumour drugs.
PubMed
Journal
Invest New Drugs
PubMed
Year
1986
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
5
iCite
Relative citation ratio, by iCite
0.23
iCite
Revised in PubMed
2026-10-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hill BTB T
2Whelan RDR D

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic AgentsMajor topic
Organometallic CompoundsMajor topic
Spiro CompoundsMajor topic
Animals
Antineoplastic Combined Chemotherapy Protocols
Cell Line
Cell Survival
Drug Resistance
Humans

Source PubMed

Download CSV of topics

References22

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17060033Rationale for the use of alternating non-cross-resistant chemotherapy.Cancer Treat Rep1982https://conductscience.org/library/papers/7060033PubMed
23909806A phase II study of spirogermanium in advanced human malignancy.Am J Clin Oncol1985https://conductscience.org/library/papers/3909806PubMed
35533992Cellular resistance to actinomycin D in Chinese hamster cells in vitro: cross-resistance, radioautographic, and cytogenetic studies.Cancer Res1970https://conductscience.org/library/papers/5533992PubMed
4343804An in vitro colony assay for human tumours grown in immune-suppressed mice and treated in vivo with cytotoxic agents.Br J Cancer1978https://conductscience.org/library/papers/343804PubMed
54357757A human cell line from a pleural effusion derived from a breast carcinoma.J Natl Cancer Inst1973https://conductscience.org/library/papers/4357757PubMed
66947891Concepts for controlling drug-resistant tumor cells.Eur J Cancer (1965)1980https://conductscience.org/library/papers/6947891PubMed
76354434Multidrug-resistance phenotype in Chinese hamster ovary cells.Cancer Treat Rep1983https://conductscience.org/library/papers/6354434PubMed
87200828Cytotoxic effects and biological activity of 2-aza-8-germanspiro[4,5]-decane-2-propanamine-8,8-diethyl-N,N-dimethyl dichloride (NSC 192965; spirogermanium) in vitro.Cancer Res1982https://conductscience.org/library/papers/7200828PubMed
96678870Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity.Invest New Drugs1983https://conductscience.org/library/papers/6678870PubMed
10709555In vivo characteristics of resistance and cross-resistance of an adriamycin-resistant subline of P388 leukemia.Cancer Treat Rep1978https://conductscience.org/library/papers/709555PubMed
114855907Reduced permeability in CHO cells as a mechanism of resistance to colchicine.J Cell Physiol1974https://conductscience.org/library/papers/4855907PubMed
126137059Cell surface P-glycoprotein associated with multidrug resistance in mammalian cell lines.Science1983https://conductscience.org/library/papers/6137059PubMed
13986302The value of adriamycin in overcoming resistance to methotrexate in tissue culture.Eur J Cancer (1965)1976https://conductscience.org/library/papers/986302PubMed
147105380Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities.Cancer Chemother Pharmacol1982https://conductscience.org/library/papers/7105380PubMed
15281559Resistance and cross-resistance of cultured leukemia P388 cells to vincristine, adriamycin, adriamycin analogs, and actinomycin D.J Natl Cancer Inst1978https://conductscience.org/library/papers/281559PubMed
166576190Preclinical screening for drugs effective against 5-fluorouracil-resistant cells with a murine L5178Y cell line in vitro.J Natl Cancer Inst1983https://conductscience.org/library/papers/6576190PubMed
176354435Vinca alkaloid-resistant phenotype in cultured human leukemic lymphoblasts.Cancer Treat Rep1983https://conductscience.org/library/papers/6354435PubMed
182857774Detection of P-glycoprotein in ovarian cancer: a molecular marker associated with multidrug resistance.J Clin Oncol1985https://conductscience.org/library/papers/2857774PubMed
1957118Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity.J Cell Physiol1976https://conductscience.org/library/papers/57118PubMed
206540761Identification of synergistic combinations of spirogermanium with 5-fluorouracil or cisplatin using a range of human tumour cell lines in vitro.Invest New Drugs1984https://conductscience.org/library/papers/6540761PubMed

See all 22 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.

PMIDTitleJournalYearIn PapersSource
37687127A Theoretical Investigation of Novel Sila- and Germa-Spirocyclic Imines and Their Relevance for Electron-Transporting Materials and Drug Discovery.Molecules2023https://conductscience.org/library/papers/37687127PubMed
2924371Comparative effectiveness of mitoxantrone and doxorubicin in overcoming experimentally induced drug resistance in murine and human tumour cell lines in vitro.Cancer Chemother Pharmacol1989https://conductscience.org/library/papers/2924371PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3583643

GET https://conductscience.org/api/papers/v1/3583643/references?page=2